Difficulty: Medium
Average Score: 62%
Practice
Which of the following cholinomimetics activates both muscarinic and nicotinic receptors?
Correct answer
C
Rationale
The correct answer is C) Nicotine. Nicotine is a cholinomimetic drug that activates both muscarinic and nicotinic receptors.
Nicotine acts as an agonist at both types of cholinergic receptors, leading to various physiological effects in the body. By activating muscarinic receptors, it can stimulate smooth muscle contraction and glandular secretions. At the same time, by binding to nicotinic receptors, it can enhance neurotransmission at autonomic ganglia and skeletal neuromuscular junctions.
Now, let's analyze why the other options are incorrect:
A) Lobeline: Lobeline is a nicotinic receptor agonist but does not activate muscarinic receptors.
B) Pilocarpine: Pilocarpine is a muscarinic receptor agonist but does not activate nicotinic receptors.
D) Bethanechol: Bethanechol is a muscarinic receptor agonist but does not activate nicotinic receptors.
In an educational context, understanding the specificity of different cholinomimetic drugs in activating muscarinic and nicotinic receptors is crucial for pharmacology students. This knowledge helps in predicting the potential effects and side effects of these drugs in clinical practice. Remembering the specific actions of each drug based on receptor activation is essential for safe and effective pharmacological interventions.
Nicotine acts as an agonist at both types of cholinergic receptors, leading to various physiological effects in the body. By activating muscarinic receptors, it can stimulate smooth muscle contraction and glandular secretions. At the same time, by binding to nicotinic receptors, it can enhance neurotransmission at autonomic ganglia and skeletal neuromuscular junctions.
Now, let's analyze why the other options are incorrect:
A) Lobeline: Lobeline is a nicotinic receptor agonist but does not activate muscarinic receptors.
B) Pilocarpine: Pilocarpine is a muscarinic receptor agonist but does not activate nicotinic receptors.
D) Bethanechol: Bethanechol is a muscarinic receptor agonist but does not activate nicotinic receptors.
In an educational context, understanding the specificity of different cholinomimetic drugs in activating muscarinic and nicotinic receptors is crucial for pharmacology students. This knowledge helps in predicting the potential effects and side effects of these drugs in clinical practice. Remembering the specific actions of each drug based on receptor activation is essential for safe and effective pharmacological interventions.